SARS-CoV-2 Process Control (Swab) - Product Usage: intended for use as an external, non-viable co...
FDA Device Recall #Z-2487-2021 — Class II — August 20, 2021
Recall Summary
| Recall Number | Z-2487-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 20, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Microbiologics Inc |
| Location | Saint Cloud, MN |
| Product Type | Devices |
| Quantity | 127 |
Product Description
SARS-CoV-2 Process Control (Swab) - Product Usage: intended for use as an external, non-viable control material to evaluate the performance of nucleic acid tests that detect SARS-CoV-2 virus.
Reason for Recall
The product indicated is contaminated with a plasmid DNA that contains the target SARS-CoV-2 sequences.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IL, MD, MT, MN, NC, NY, NV, OR, TN, TX,UT, WA and WI. The countries of Austria, Canada, Colombia, France, Germany, Hong Kong, India, Ireland, Italy, Japan and United Kingdom.
Lot / Code Information
Catalog # HE0063S Lot #'s: HE0063-100-1, HE0063-103-2, HE0063-103-3, HE0063-103-1, HE0063-104-1, HE0063-101-1 and HE0063-100-1.
Other Recalls from Microbiologics Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0986-2026 | Class II | LYFO DISK, Campylobacter jejuni subsp. jejuni d... | Dec 2, 2025 |
| Z-0984-2026 | Class II | KWIK-STIK 2-Pack, Campylobacter jejuni subsp. j... | Dec 2, 2025 |
| Z-0985-2026 | Class II | KWIK-STIK 6-Pack, Campylobacter jejuni subsp. j... | Dec 2, 2025 |
| Z-0876-2026 | Class II | KWIK-STIK, Quality control kit for culture medi... | Nov 13, 2025 |
| Z-2194-2025 | Class II | LYFO-DISK, M. Canis Derived from ATCC 36299, pa... | Jun 27, 2025 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.